Torgauten HM[au] - Search Results

Save citations to file

Email citations

Your saved search

Your RSS Feed

Year	Number of Results
2017	1
2019	1
2021	2
2022	1

Page 1

Safety and efficacy of rituximab as first- and second line treatment in multiple sclerosis - A cohort study.

Torgauten HM, Myhr KM, Wergeland S, Bø L, Aarseth JH, Torkildsen Ø. Torgauten HM, et al. Mult Scler J Exp Transl Clin. 2021 Jan 31;7(1):2055217320973049. doi: 10.1177/2055217320973049. eCollection 2021 Jan-Mar. Mult Scler J Exp Transl Clin. 2021. PMID: 33796328 Free PMC article.

A man in his seventies with spinal cord injury, fever and delirium.

Torgauten HM, Sanaker PS, Rekand T. Torgauten HM, et al. Tidsskr Nor Laegeforen. 2019 May 6;139(8). doi: 10.4045/tidsskr.17.1104. Print 2019 May 7. Tidsskr Nor Laegeforen. 2019. PMID: 31062554 Free article. English, Norwegian.

Humoral immunity to SARS-CoV-2 mRNA vaccination in multiple sclerosis: the relevance of time since last rituximab infusion and first experience from sporadic revaccinations.

König M, Lorentzen ÅR, Torgauten HM, Tran TT, Schikora-Rustad S, Vaage EB, Mygland Å, Wergeland S, Aarseth J, Aaberge IAS, Torkildsen Ø, Holmøy T, Berge T, Myhr KM, Harbo HF, Andersen JT, Munthe LA, Søraas A, Celius EG, Vaage JT, Lund-Johansen F, Nygaard GO. König M, et al. Among authors: torgauten hm. J Neurol Neurosurg Psychiatry. 2021 Oct 20:jnnp-2021-327612. doi: 10.1136/jnnp-2021-327612. Online ahead of print. J Neurol Neurosurg Psychiatry. 2021. PMID: 34670844

Shortage of Digitoxin and Switching to Digoxin in Norway: A Retrospective Study of Blood Samples Submitted to a Clinical Pharmacology Laboratory.

Schjøtt J, Torgauten HM, Bjånes TK. Schjøtt J, et al. Among authors: torgauten hm. Basic Clin Pharmacol Toxicol. 2017 Jul;121(1):74-77. doi: 10.1111/bcpt.12770. Epub 2017 Mar 15. Basic Clin Pharmacol Toxicol. 2017. PMID: 28235161 Free article. No abstract available.

Immunogenicity and Safety of a Third SARS-CoV-2 Vaccine Dose in Patients With Multiple Sclerosis and Weak Immune Response After COVID-19 Vaccination.

König M, Torgauten HM, Tran TT, Holmøy T, Vaage JT, Lund-Johansen F, Nygaard GO. König M, et al. Among authors: torgauten hm. JAMA Neurol. 2022 Mar 1;79(3):307-309. doi: 10.1001/jamaneurol.2021.5109. JAMA Neurol. 2022. PMID: 35072702 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

Search Page

Search Results